New Multicomponent Solid Forms of the Antitumor Drug Ripretinib: The Role of Conformations in Dictating Dissolution and Photostability-Reference-Cited by-同舟云学术

New Multicomponent Solid Forms of the Antitumor Drug Ripretinib: The Role of Conformations in Dictating Dissolution and Photostability

Published:2024-09-06 Issue: Volume: Page:
ISSN:1528-7483
Container-title:Crystal Growth & Design
language:en
Short-container-title:Crystal Growth & Design

Author:

Muthaiyan Muthukumari¹,K. S Fayaz T.¹²^ORCID,Kenguva Gowtham³,Prajapati Aditya Kumar⁴,Dandela Rambabu³,Chernyshev Vladimir V.⁵⁶^ORCID,Sanphui Palash¹^ORCID

Affiliation:

1. Department of Chemistry, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu 603203, India

2. Post-Graduate and Research Department of Chemistry, The New College (Autonomous),University of Madras, Chennai 600 014, India

3. Department of Industrial and Engineering Chemistry, Institute of Chemical Technology, Indian Oil Odisha Campus, IIT Kharagpur Extension Centre, Mouza Samantapuri, Bhubaneswar, Odisha 751013, India

4. Department of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India

5. Department of Chemistry, M. V. Lomonosov Moscow State University, 1-3 Leninskie Gory, Moscow 119991, Russian Federation

6. A. N. Frumkin Institute of Physical Chemistry and Electrochemistry RAS, 31 Leninsky Prospect, Moscow 119071, Russian Federation

Funder

Science and Engineering Research Board

SRM Institute of Science and Technology

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.cgd.4c00855

Reference47 articles.

1. Drug discovery in pharmaceutical industry: productivity challenges and trends

2. Mattei, A.; Li, T. Pharmaceutical Crystals: Science and Engineering. John Wiley & Sons, Inc publisher: 2019, Vol. 10; pp. 427461.

3. Kerns, E. H.; Di, L. Comprehensive Medicinal Chemistry II. Elsevier Ltd: 2007, Vol. 5; pp. 489507.

4. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009

5. All Ranitidine Products (Zantac): Press Release - FDA Requests Removal. https://www.fda.gov/safety/medical-product-safety-information/all-ranitidine-products-zantac-press-release-fda-requests-removal, accessed 19 June 2024.